ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,842.91
0.11%
US Tech 100
20,252.00
0.24%
다우존스 지수
42,518.28
0.52%
Bitcoin
96,749.31
0.25%
Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Rockwell Medical Inc (RMTI)

  7. Rockwell Medical Inc (RMTI) 뉴스

Rockwell Medical Inc

Rockwell Medical Inc (RMTI)

NASDAQ
2.00
-0.01
(-0.50%)
마감 15 1월 6:00AM
15분 지연
2.00
0.00
( 0.00% )
시간외 단일가: 6:07PM
15분 지연

개인 투자자를 위한 전문가급 도구.

프리미엄

RMTI 뉴스

공식 뉴스 전용

Form 8-K - Current report
Edgar (US Regulatory)
12 11월 2024
RMTI (-0.50%)

Form 8-K - Current report
Edgar (US Regulatory)
12 11월 2024
RMTI (-0.50%)

Form EFFECT - Notice of Effectiveness
Edgar (US Regulatory)
22 10월 2024
RMTI (-0.50%)

Form S-8 - Securities to be offered to employees in employee benefit plans
Edgar (US Regulatory)
08 10월 2024
RMTI (-0.50%)

Form S-3 - Registration statement under Securities Act of 1933
Edgar (US Regulatory)
08 10월 2024
RMTI (-0.50%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
03 10월 2024
RMTI (-0.50%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
03 10월 2024
RMTI (-0.50%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
02 10월 2024
RMTI (-0.50%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
02 10월 2024
RMTI (-0.50%)

RMTI Discussion

게시물 보기
glenn1919 glenn1919 2 월 전
RMTI........................................https://stockcharts.com/h-sc/ui?s=RMTI&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 4 월 전
RMTI.......................................https://stockcharts.com/h-sc/ui?s=RMTI&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 4 월 전
RMTI.......................................https://stockcharts.com/h-sc/ui?s=RMTI&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 5 월 전
RMTI..................................https://stockcharts.com/h-sc/ui?s=RMTI&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 7 월 전
RMTI.............................https://stockcharts.com/h-sc/ui?s=RMTI&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 10 월 전
RMTI..........................https://stockcharts.com/h-sc/ui?s=RMTI&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 10 월 전
RMTI............................................https://stockcharts.com/h-sc/ui?s=RMTI&p=W&b=5&g=0&id=p86431144783
👍️0
triannual triannual 11 월 전
Price targets are as low as $5. I'm in @ $1.22. The quarterly numbers have gotten better. I guess we will know on March 21st.Good luck
👍️ 1
4Godnwv 4Godnwv 11 월 전
This thing has not been healthy in a while. I lost money on it last year, not sure why I’m even looking at it again. It took another major hit when they lowered guidance in January. The chart looks interesting, but charts don’t run on smoke and mirrors, they need material events to cause them to change directions. Watching - 4God
👍️0
triannual triannual 11 월 전
Press Release: Rockwell Medical to Release Fourth Quarter and Full-Year 2023 Results on Thursday, March 21, 2024.
The numbers better be really good. If not it's lights out. They will end up on the OTC. GLTA
👍️0
triannual triannual 11 월 전
In @ $1.22
👍️0
4Godnwv 4Godnwv 1 년 전
Recent news has stopped the bleeding. Expect Q3 numbers to lift the ppps here.
👍️0
4Godnwv 4Godnwv 1 년 전
This thing got taken to the chopping block, but HC Wainwright may have pulled its bacon out of the fire.
👍️0
willlbone willlbone 2 년 전
Seems like they might dump 10 million shares at $1.39.
👍️0
Triple nickle Triple nickle 2 년 전
They beat estimates by almost double
Impressive outcome
👍️0
Jayzp Jayzp 2 년 전
rmti vs ther

Ther can be big,with good news

https://www.prnewswire.com/news-releases/theralink-acquires-exclusive-landmark-immunotherapy-patent-including-biomarker-from-vanderbilt-university-301787847.html
👍️0
tw0122 tw0122 2 년 전
Going up quick
👍️0
makinezmoney makinezmoney 2 년 전
$RMTI: Shes havng a nice day today.... now $1.30


Nice run up there on the daily chart



GO $RMTI
👍️0
GTF GTF 2 년 전
New ceo trying to get back to basics...get the biz profitable without relying on Triferic.
👍️0
duderaja duderaja 3 년 전
Correct me if I'm wrong, but after the r/s the price should be 2.37 and it's 2.02 in pre-market which means it has dropped .35 in pre-market.
👍️0
Triple nickle Triple nickle 3 년 전
Premarket looks promising
👍️0
willlbone willlbone 3 년 전
Rock Bottom.
👍️0
TSCTOlson TSCTOlson 3 년 전
$RMTI is scheduled to present at Aegis Virtual Conference, on Wednesday, February 23rd at 1:30 - 2:00 PM ET.
https://ih.advfn.com/stock-market/NASDAQ/rockwell-medical-RMTI/stock-news/87292951/rockwell-medical-inc-to-present-at-aegis-virtual
👍️0
instock58 instock58 3 년 전
RMTI NEWS " Rockwell Medical Announces Regulatory Approval of Triferic® Dialysate in South Korea
https://finance.yahoo.com/news/rockwell-medical-announces-regulatory-approval-141500983.html

UP 1% and starting to rise...News just our 25 mins ago...
Heavy Volume Picking up ...becoming heavier..

https://finance.yahoo.com/quote/RMTI?p=RMTI


Finviz
https://finviz.com/quote.ashx?t=RMTI


TradingView Buy Rated
https://www.tradingview.com/symbols/NASDAQ-RMTI/


$RMTI




👍️0
JetBlueJason JetBlueJason 3 년 전
Agreed....
Needs some news to sustain it.

Murocman
👍️0
murocman murocman 3 년 전
Needs some news to sustain it.

Murocman
👍️0
JetBlueJason JetBlueJason 3 년 전
Moving North for sure $$$$$$
$RMTI
👍️0
TSCTOlson TSCTOlson 3 년 전
$RMTI will have huge breakout from here, I think
👍️0
CarlCarlMcB CarlCarlMcB 3 년 전
We be going North $$$$$:) air !!!!
👍️0
Bigbruin Bigbruin 3 년 전
Good morning from miami fla
Why is this moving up anyone ?
👍️0
CarlCarlMcB CarlCarlMcB 3 년 전
Merry Christmas $$$$$$$:)
👍️0
TheFinalCD TheFinalCD 3 년 전
https://finance.yahoo.com/news/rockwell-medical-study-demonstrates-no-210100032.html

https://ih.advfn.com/stock-market/NASDAQ/rockwell-medical-RMTI/stock-news/86578594/rockwell-medical-study-demonstrates-no-drug-drug-i
👍️0
BlazingStocks BlazingStocks 3 년 전
A live webcast of the call will be available under "Events & Presentations" in the Investor section of the Company's website, https://ir.rockwellmed.com/. An archived webcast will be available on the Company's website approximately two hours after the event and will be available for 30 days.

To submit questions in advance, please email your questions to invest@rockwellmed.com.

$RMTI
👍️0
budfoxfun budfoxfun 3 년 전
$RMTI Rockwell Medical, Inc. to Report Second Quarter 2021 Financial and Operating Results on August 16, 2021 https://finance.yahoo.com/news/rockwell-medical-inc-report-second-110000902.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr via @Yahoo
👍️0
BlazingStocks BlazingStocks 3 년 전
$RMTI News July 29, 2021

Rockwell Medical, Inc. to Report Second Quarter 2021 Financial and Operating Results on August 16, 2021
https://finance.yahoo.com/news/rockwell-medical-inc-report-second-110000902.html
👍️0
budfoxfun budfoxfun 3 년 전
Green heading into the close!

RMTI
👍️0
BlazingStocks BlazingStocks 3 년 전
$RMTI trading at approximately 30% of its 10-day average volume...but it's trading green.
👍️0
BlazingStocks BlazingStocks 3 년 전
$RMTI will be able to tap into a largely under serviced patient pool...
👍️0
budfoxfun budfoxfun 3 년 전
$RMTI announced that it has submitted a pre-IND (Investigational New Drug) meeting request with the U.S. Food and Drug Administration (FDA) in support of its proposed Phase 2 clinical trial of Ferric Pyrophosphate Citrate (FPC), designed for the treatment of iron deficiency anemia and maintenance of hemoglobin in patients receiving infusion therapy in the home setting.

Home infusion represents a large and rapidly growing segment of healthcare. Many patient groups requiring home infusion therapies suffer from chronic diseases that are associated with a high incidence of iron deficiency and anemia. For example, it is estimated that 40%-55% of all home parenteral nutrition patients are iron deficient. Current treatment patterns can be inadequate for patients on home infusion therapy with iron deficiency anemia, causing them to suffer extreme fatigue and can result in serious health risks, such as, poor immune function and heart failure.
👍️0
BlazingStocks BlazingStocks 3 년 전
PRODUCING AND DELIVERING HEMODIALYSIS CONCENTRATES AND ANCILLARY PRODUCTS TO DIALYSIS PROVIDERS

Rockwell Medical, $RMTI, is an innovative leader in producing and delivering hemodialysis concentrates (solutions and powders) along with related ancillary products to dialysis providers located throughout the U.S. and abroad.

Rockwell Medical is dedicated to providing the hemodialysis community with the highest quality products supported by the most reliable delivery service in the industry. Rockwell has multiple manufacturing locations throughout the United States to ensure fast and efficient delivery of our products. The company adheres to Good Manufacturing Practices (GMPs) and to the Association for Advancement of Medical Instrumentation (AAMI) standards in our manufacturing, ensuring a high-quality hemodialysate known throughout the industry for safety and excellence.

Our customer service department is dedicated to the fundamental principle that our customers are the most important part of our business. Our representatives strive to provide the highest level of courtesy and efficiency to our customers. Rockwell Medical is an independent supplier that does not own or operate dialysis clinics. Our focus is on providing customers with quality dialysis products.

https://www.rockwellmed.com/hemodialysis-concentrates/supporting-dialysis-providers/
👍️0
budfoxfun budfoxfun 3 년 전
$RMTI Rockwell Medical is a commercial-stage biopharmaceutical company developing and commercializing its next-generation parenteral iron technology platform, Ferric Pyrophosphate Citrate (FPC), which has the potential to lead transformative treatments for iron deficiency in multiple disease states, reduce healthcare costs and improve patients’ lives.

The Company has two FDA-approved therapies indicated for patients undergoing hemodialysis, which are the first two products developed from the FPC platform. The Company is developing FPC for the treatment of iron deficiency in patients outside of dialysis, who are receiving intravenous medications in the home infusion setting, a large and rapidly growing segment of healthcare, and where these patients suffer from chronic diseases associated with high incidence of iron deficiency and anemia.

In addition, Rockwell Medical is one of two major suppliers of life-saving hemodialysis concentrate products to kidney dialysis clinics in the United States. For more information, visit www.RockwellMed.com.
👍️0
BlazingStocks BlazingStocks 3 년 전
Once we see updates from the FDA on this, $RMTI will see a great run...
👍️0
budfoxfun budfoxfun 3 년 전
“This is an important step for Rockwell Medical and home infusion patients as we believe that FPC is uniquely suited to address this important unmet clinical need,” said Russell Ellison, M.D., President and Chief Executive Officer of Rockwell Medical. “We expect to finalize our Phase 2 clinical study design and protocol with the advice and guidance of the FDA.”

RMTI
👍️0
BlazingStocks BlazingStocks 3 년 전
I found this page of the website interesting and informative, to help me understand why this technology is so special.

https://www.rockwellmed.com/our-technology/technology-platform/

PLATFORM TECHNOLOGY TO MANAGE IRON IN A NEW WAY
Ferric pyrophosphate citrate (FPC) is a novel complex iron salt, developed to replace iron losses in patients with anemia in an entirely new way. This unique and differentiated molecule consists of an iron atom complexed to one pyrophosphate and two citrate anions. This formulation has been shown to allow for rapid donation of iron to transferrin, protein in the blood that binds to iron and transports it through the body, including to the bone marrow. This mechanism uses the body’s own means to transport iron safely to tissues that need iron (i.e. red blood cells and muscle).
👍️0
budfoxfun budfoxfun 3 년 전
$RMTI a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management and improving outcomes for patients around the world, today announced that it has submitted a pre-IND (Investigational New Drug) meeting request with the U.S. Food and Drug Administration (FDA) in support of its proposed Phase 2 clinical trial of Ferric Pyrophosphate Citrate (FPC), designed for the treatment of iron deficiency anemia and maintenance of hemoglobin in patients receiving infusion therapy in the home setting.

Home infusion represents a large and rapidly growing segment of healthcare. Many patient groups requiring home infusion therapies suffer from chronic diseases that are associated with a high incidence of iron deficiency and anemia. For example, it is estimated that 40%-55% of all home parenteral nutrition patients are iron deficient. Current treatment patterns can be inadequate for patients on home infusion therapy with iron deficiency anemia, causing them to suffer extreme fatigue and can result in serious health risks, such as, poor immune function and heart failure.
👍️0
BlazingStocks BlazingStocks 3 년 전
Agreed, the $RTMI volume has decreased but the price action has been steady.
👍️0
budfoxfun budfoxfun 3 년 전
Nice support at these levels!

RMTI
👍️0
BlazingStocks BlazingStocks 3 년 전
It's an interesting new technology...$RMTI

In addition, FPC iron is delivered regardless of other underlying conditions which might otherwise block the release of iron. Some of the challenges of managing iron in sick patients, including inflammation, hepcidin block, and functional iron deficiency, can be overcome with FPC due to its ability to provide bioavailable iron.

FPC is highly soluble in water and, therefore, can be formulated for parenteral administration either by the dialysis solution or intravenously. As a result, this novel approach to iron management has the potential for application in the treatment of anemia in many disease states.
👍️0
ProfitScout ProfitScout 3 년 전
The RMTI approach to anemia treatment is a clear advancement and holds great promise for improving the lives of millions of people who suffer from this problem around the world.

From the company website:

PLATFORM TECHNOLOGY TO MANAGE IRON IN A NEW WAY

Ferric pyrophosphate citrate (FPC) is a novel complex iron salt, developed to replace iron losses in patients with anemia in an entirely new way. This unique and differentiated molecule consists of an iron atom complexed to one pyrophosphate and two citrate anions. This formulation has been shown to allow for rapid donation of iron to transferrin, protein in the blood that binds to iron and transports it through the body, including to the bone marrow. This mechanism uses the body’s own means to transport iron safely to tissues that need iron (i.e. red blood cells and muscle).

Read more here:
https://www.rockwellmed.com/our-technology/technology-platform/
👍️0
BlazingStocks BlazingStocks 3 년 전
$RMTI volume right around 20% of its 10-day average volume but trading GREEN!
👍️0

최근 히스토리

NASDAQ
RMTI
Rockwell Medical
BIT
P1IEM1
BNP Paribas Issuance
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유